Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Ventaire, Caytine
Synonyms :
Methylenedioxyphenyl-isoproterenol
Class :
Î’-adrenergic receptor agonist/bronchodilator
Data not availableÂ
Refer to adult dosingÂ
When protokylol is used together with mebhydrolin, protokylol’s therapeutic effectiveness can be enhanced
the therapeutic effect of acebutolol may be increased
the risk of cardiac arrhythmia may be increased
the risk of cardiac arrhythmia may be increased
the therapeutic effect of protokylol may be increased
the risk of tachycardia may be increased
the therapeutic effect of protokylol may be increased
the risk of cardiac arrhythmia may be increased
the risk of hypokalemia may be increased
amitriptylinoxide(Phase 4 Clinical Trials)Â
the risk of hypertension may be increased
the therapeutic effect of amphetamine may be increased
the risk of tachycardia may be increased
the therapeutic effect of protokylol may be increased
the risk of adverse effects may be increased
the therapeutic effects of protokylol may be increased
the risk of adverse effects may be increased
the risk of tachycardia may be increased
the risk of hypokalemia may be increased
the risk of tachycardia may be increased
the hypertensive activity of protokylol may be increased
the risk of hypertension may be increased
the therapeutic effect of protokylol may be increased
Actions and spectrum:Â
To activate intracellular adenyl cyclase, which catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3′,5′-adenosine monophosphate (cAMP), protokylol binds to beta-2 adrenergic receptors in bronchial smooth muscle.
Elevated levels of cAMP relax the smooth muscle in the bronchi, alleviate spasms in the bronchi, enhance mucociliary clearance, and prevent the release of mediators of hypersensitivity from cells, particularly mast cells.Â
Frequency not definedÂ
TremorsÂ
TachycardiaÂ
Metabolic effectsÂ
Black Box Warning Â
No special warnings are available for this drugÂ
Contraindication/Caution:Â
Contraindication:Â
Hypersensitivity Â
Pregnancy consideration:Â Â
USFDA pregnancy category: Not assignedÂ
Lactation:Â Â
Data about the excretion of protokylol into breast milk is not knownÂ
Pregnancy category:Â Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus `in either the first or second trimester.Â
Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:Â
Protokylol is an agonist of β-adrenergic receptor.Â
Pharmacodynamics:Â
Protokylol produces a bronchodilation effect by acting as an agonist of TRPV1.Â
Pharmacokinetics:Â
Limited data availableÂ
Administration:Â
To be administered as directed by the doctorÂ
Patient information leafletÂ
Generic Name: protokylolÂ
Why do we use protokylol?Â
Protokylol is a beta-adrenergic receptor agonist. It acts as a bronchodilator, and it is indicated in the treatment of asthma and other respiratory illnesses.Â